DCPH - Deciphera Pharmaceuticals LLC - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DCPH is currently covered by 10 analysts with an average price target of $37.76. This is a potential upside of $12.17 (47.56%) from yesterday's end of day stock price of $25.59.

Deciphera Pharmaceuticals LLC's activity chart (see below) currently has 83 price targets and 83 ratings on display. The stock rating distribution of DCPH is 72.73% BUY, 9.09% SELL and 18.18% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 57.64% with an average time for these price targets to be met of 224.86 days.

Highest price target for DCPH is $26, Lowest price target is $25.6, average price target is $37.76.

Most recent stock forecast was given by PETER LAWSON from BARCLAYS on 30-Apr-2024. First documented stock forecast 23-Oct-2017.

Currently out of the existing stock ratings of DCPH, 16 are a BUY (72.73%), 2 are a SELL (9.09%), 4 are a HOLD (18.18%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

$26

$0.41 (1.60%)

$9

6 months 21 days ago
(30-Apr-2024)

3/10 (30%)

$0.73 (2.89%)

235

Buy

$23

6 months 21 days ago
(30-Apr-2024)

4/6 (66.67%)

$8.58 (59.50%)

353

Buy

$22

6 months 21 days ago
(30-Apr-2024)

2/3 (66.67%)

$2.24 (11.34%)

67

Buy

$25.6

$0.01 (0.04%)

6 months 22 days ago
(29-Apr-2024)

0/3 (0%)

$10.95 (74.74%)

Hold

$14

$-11.59 (-45.29%)

$52

1 years ago
(20-Nov-2023)

4/4 (100%)

$1.66 (13.45%)

92

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DCPH (Deciphera Pharmaceuticals LLC) average time for price targets to be met?

On average it took 224.86 days on average for the stock forecasts to be realized with a an average price target met ratio 57.64

Which analyst has the current highest performing score on DCPH (Deciphera Pharmaceuticals LLC) with a proven track record?

ARLINDA LEE

Which analyst has the most public recommendations on DCPH (Deciphera Pharmaceuticals LLC)?

Arlinda Lee has 4 price targets and 5 ratings on DCPH

Which analyst is the currently most bullish on DCPH (Deciphera Pharmaceuticals LLC)?

Konstantinos Aprilakis with highest potential upside - $62.28

Which analyst is the currently most reserved on DCPH (Deciphera Pharmaceuticals LLC)?

Jessica Fye with lowest potential downside - -$11.59

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?